The Subcutaneous Drug Delivery Devices Market Size is valued at USD 30.9 Bn in 2023 and is predicted to reach USD 55.7 Bn by the year 2031 at an 7.9% CAGR during the forecast period for 2024-2031.
Subcutaneous drug delivery devices are specific systems designed to deliver drugs directly into the subcutaneous tissue, that is, just below the skin. Examples include syringes and autoinjectors to wearable infusion pumps for medicines that require absorption slowly into the bloodstream. SC injections are administered for a wide range of therapeutic applications; these include chronic conditions such as diabetes (insulin) and autoimmune diseases (biologics), emergency treatments such as EpiPens for allergic reactions, and some vaccinations. This administration route is very convenient for self-administration.
Increasing demand for self-administration is one of the primary driving factors behind this expansion of subcutaneous drug delivery devices in the market. Patients are growing to seek methods that would allow them to manage their treatments at home, thus reducing their frequent visits to healthcare facilities and increasing adherence to prescribed regimens. This is congruent with the increasing trend of personalized medicine and even home healthcare solutions, quite convenient for enhanced patient comfort, necessary both for healthcare providers and patients.
The subcutaneous drug delivery devices market is segmented by product, distribution channel. By product the market is segmented into prefilled syringes, pen injectors, auto injectors, wearable injectors, needle-free injectors. By distribution channel market is categorized hospital pharmacies, retail pharmacies, online pharmacies.
Increase in use of prefilled syringes is one of the most important drivers for market growth of the subcutaneous drug delivery devices. Since the syringes already have medication, the administration procedure is much easier with fewer chances to make dosing errors. This is particularly valuable for self-administration, where injections can be conducted on an impromptu basis with no need for elaborate training. Prefilled syringes also ensure the safety of patients through accurate dosing and minimizing contamination and needle-stick injuries risks, among other benefits that improve treatment outcomes and compliance. While they cost more upfront, they can save money in the long term by minimizing wastage of drugs, estimated to be 20-30% less than vials, and repeated visits to the healthcare system, which subsequently save money.
Online pharmacies are developing quickly as the fastest-growing distribution channel in the subcutaneous drug delivery devices market, driven by convenience, privacy, and cost-effectiveness. The platform offers patients, including chronic patients, the added convenience to order drugs from home, thereby avoiding frequent trips to physical stores. The discreet shopping experience appeals to the individual purchasing sensitive medications, and competitive pricing and promotions render the platform appealing to the cost-conscious consumer. For example, the better are the online health services, including consulting and prescription management, the greater the usability and confidence in the online shopping process.
At present, North America dominates the subcutaneous drug delivery devices market. Its highly developed health care infrastructure, high rates of chronic diseases, massive investment in medical technologies, and strong reimbursement systems are the key factors influencing demand for this market. Established healthcare centers and access to state-of-the-art medical services in this region enable the mass use of innovative subcutaneous drug delivery systems. Increasing numbers of patients suffering from chronic diseases, such as diabetes and rheumatoid arthritis, increase demand for these devices. The leading pharmaceuticals industry in North America invests considerably in R&D to accelerate drug delivery technologies. Complete healthcare reimbursement policies also ensure patient access and adoption.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 30.9 Bn |
|
Revenue Forecast In 2031 |
USD 55.7 Bn |
|
Growth Rate CAGR |
CAGR of 7.9 % from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product, By Distribution Channel, and By Region |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; Southeast Asia |
|
Competitive Landscape |
Gerresheimer AG, Medtronic Plc, Ypsomed AG, Elcam Medical Group, Novo Nordisk, Insulet Corporation, Becton, Dickinson and Company, West Pharmaceutical Services, Inc., PharmaJet, Unilife Corporation, Inolife Sciences |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Subcutaneous Drug Delivery Devices Market by Product -
Subcutaneous Drug Delivery Devices Market by Distribution Channel -
Subcutaneous Drug Delivery Devices Market by Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
